Stay updated with breaking news from Certain Cash Value. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
All that really matters is if the Federal Reserve announces an interest-rate cut on June 12. Until then, everything that crosses the tape-from earnings reports to economic data-is commentary or, at... -April 03, 2024 at 06:22 am EDT - MarketScreener
Tafasitamab sold to IncyteNovartis to launch a voluntary public takeover offer for all MorphoSys shares at a price of € 68.00 per share in cashShareholders benefit from attractive premium of 94 percent to the one-month volume weighted average price before January 25, 2024Novartis provides ample resources to maximize...
Germany - MorphoSys AG today announced the company entered into a Business Combination Agreement with Novartis data42 AG and Novartis AG based on Novartis' intention to submit a voluntary public...